NEKTAR THERAPEUTICS Annual Earnings Per Share, Basic in USD/shares from 2016 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Nektar Therapeutics quarterly/annual Earnings Per Share, Basic history and growth rate from 2016 to 2023.
  • Nektar Therapeutics Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.25 USD/shares, a 7.41% increase year-over-year.
  • Nektar Therapeutics Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.89 USD/shares, a 45.4% increase year-over-year.
  • Nektar Therapeutics annual Earnings Per Share, Basic for 2023 was -1.45 USD/shares, a 26.4% increase from 2022.
  • Nektar Therapeutics annual Earnings Per Share, Basic for 2022 was -1.97 USD/shares, a 31.1% increase from 2021.
  • Nektar Therapeutics annual Earnings Per Share, Basic for 2021 was -2.86 USD/shares, a 14.9% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.52 +26.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$2 +$0.89 +31.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$3 $0 -14.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$2 +$0.03 +1.19% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$3 -$7 -163% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $4.02 +$4.64 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$1 +$0.48 +43.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$1 Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.